Dr. Liang is Professor of Medicine at Harvard Medical School and Professor of Health Policy and Management at Harvard School of Public Health and is based at the Brigham and Women’s Hospital (BWH) and the Massachusetts Veteran’s Epidemiology Research and Information Center (MAVERIC). He is a graduate of Johns Hopkins University in philosophy and chemistry, Harvard Medical School, and the Harvard School of Public Health (HSPH) in tropical public health and epidemiology. He founded and directed the Robert B. Brigham Arthritis and Musculoskeletal Diseases Clinical Research Center at the Brigham and Women's Hospital between 1977-2002 and is currently its Director of Special Projects. He is Medical Director of Rehabilitation Services at Brigham and Women's Hospital. Dr. Liang is a founding faculty member of the Clinical Effectiveness Program at HSPH and is a member of the BWH Research Institute’s Clinical Research Committee.
Dr. Liang also directs the Center for Advanced Methodological Support for Innovative SLE Trials (ASSIST), and is the Chief of the Section of Rheumatology at the VA Boston Healthcare System, and a Study Director in the VA Cooperative Studies Program (CSP). The CSP has conducted over 550 multicenter clinical trials since its inception. Dr. Liang has served on the Advisory Council of the National Institute of Arthritis, Musculoskeletal and Skin Diseases, and is currently on the Boards of the Alliance for Lupus Research, the Lupus Clinical Trials Consortium, and Rheuminations, Inc. He serves on the editorial boards of Arthritis and Rheumatism,Lupus, SPINE, The American Journal of Medicine, Nature Clinical Practice Rheumatology, Patient Care, and Current Rheumatology Reviews. He is an active primary care physician and rheumatologist and was named one of the Best Doctors in America.
He is a recipient of the Lawrence Poole Prize in Rehabilitation from the University of Edinburgh, the Lee C. Howley Sr. Prize for Research in Arthritis, the Kirkland Scholar Award and the American College of Rheumatology Award of Distinction for Clinical Research. He is a consultant to the Food and Drug Administration, the Shriners Hospital - Boston, Hong Kong Research Council, the Arthritis Research Center of Canada, and the Office of the Clinical director of the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
His current research interests include basic methodologic work in clinimetrics, clinical trials methodology in systemic lupus erythematosus, the epidemiology of rheumatic disease and disability, prevention of Lyme disease, outcomes research, the identification of modifiable risk factors in high risk and disadvantaged populations, clinical decision making, and prevention of osteoarthritis.
Congress e-Store
